The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: Experience at a teaching hospital

Asia-Pacific Journal of Public Health

Volumn 27, Issue 2, 2015, Pages NP1793-NP1804

  Wang, Jui ^a   Chiu, Wei Hsiu ^b,c,d,e,f   Chen, Ran Chou ^b,g   Chen, Fu Li ^a   Tung, Tao Hsin ^a,h  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Central Clinic and Hospital   (Taiwan)

^d JINAN UNIVERSITY   (China)

^e Hungchi Women and Children's Hospital   (Taiwan)

^f Qisda Corporation   (Taiwan)

^g TAIPEI CITY HOSPITAL   (Taiwan)

^h CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

nonalcoholic fatty liver disease; occupational population; prevalence

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; AGE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BODY MASS; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OCCUPATION; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TAIWAN; TEACHING HOSPITAL;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HOSPITALS, TEACHING; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OCCUPATIONS; PREVALENCE; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 84926351184     PISSN: 10105395     EISSN: 19412479     Source Type: Journal    
DOI: 10.1177/1010539513483830     Document Type: Article

References (33)

1. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol. 2008 ; 103: 2263-2271
2. Barshop NJ, Sirlin CB, Scheimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008 ; 28: 13-24
3. Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008 ; 44: 792-798
4. Syn WK, Nightingale P, Bateman JM. Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors. Hepatol Int. 2008 ; 2: 190-195
5. Chen TW, Chou YS, Yang CJ, et al. Work stress induces non-alcoholic steatohepatitis - an experience in a Northern Taiwan survey. Chinese J Occup Med. 2008 ; 15: 227-238
6. Hsiao TM, Chau TT, Shen MS, et al. Risk factors of fatty liver among electronic employees in North Taiwan. Taiwan J Fam Med. 2007 ; 17: 189-198
7. Caballería L, Auladell MA, Torán P, et al. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterol. 2008 ; 8: 44
8. Li H, Wang YJ, Tan K, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009 ; 8: 377-382
9. Ferreira VSG, Pernambuco RB, Lopes EP, et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metab. 2010 ; 54: 362-368
10. De Alwis NMW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008 ; 48: 104-112
11. Yeh CH, Yen SC. Evaluation the related factors of fatty liver in labors physical examination. Chinese J Occup Med. 2004 ; 11: 57-70
12. Lin YC, Chou SC, Huang PT, Chiou HY. Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan. Ann Hepatol. 2011 ; 10: 125-132
13. Tsai CH, Lee YC, Ro YC, et al. Non-alcoholic fatty liver disease and obesity-associated factors: a study in a regional hospital in Mid-Taiwan. Taiwan J Fam Med. 2006 ; 16: 215-225
14. Wang PM, Chau TT, Tseng SC, et al. Risk factors investigation of fatty liver in patients receiving health checkups: a medical center base study. Taiwan J Fam Med. 2008 ; 18: 111-123
15. Dai HF, Shen Z, Yu CH, Zhang XC, Li YM. Epidemiology of fatty liver in an islander population of China: a population-based case-control study. Hepatobiliary Pancreat Dis Int. 2008 ; 7: 373-378
16. Onyekwere CA, Ogbera AO, Balogun BO. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Ann Hepatol. 2011 ; 10: 119-124
17. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern. Ital J Gastroenterol Hepatol. 1997 ; 29: 351-356
18. Fan JG. Steatohepatitis studies in China. Shijie Huaren Xiaohua Zazhi. 2001 ; 9: 6-10
19. Fan JG, Zhu J, Li XJ, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005 ; 20: 1825-1832
20. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009 ; 50: 204-210
21. Wang Z, Xia B, Ma C, Hu Z, Chen X, Cao P. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad Med J. 2007 ; 83: 192-195
22. Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006 ; 21: 138-143
23. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008 ; 28: 339-350
24. Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology. 2003 ; 124: 248-250
25. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int. 2007 ; 6: 572-578
26. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002 ; 35: 373-379
27. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003 ; 37: 917-923
28. Loguercio C, Nardone G, Sicolo P, Cuomo R, Del Vecchio C, Budillon G. Intravenous load of fructose and fructose 1,6-diphosphate: effects on uricemia in patients with nonalcoholic liver disease. Am J Gastroenterol. 1996 ; 91: 559-564
29. Liu CM, Tung TH, Liu JH, et al. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol. 2005 ; 11: 1616-1622
30. Tung TH, Chang TH, Chiu WH, et al. Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: experience at a teaching hospital. BMC Res Notes. 2011 ; 4: 315
31. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000 ; 342: 1266-1271
32. Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. The important of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol. 2007 ; 22: 663-668
33. Chen CH, Huang MH, Yang JC, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol. 2007 ; 22: 1482-1489